Award Year / Program / Phase:2010 / SBIR / Phase I
Agency:HHS
Principal Investigator:Alex Tong
Award Amount:$199,045.00
Abstract:
The three basic requirements for an effective RNA interference-based therapy are 1) identification of key genetic defect[s] that provide pivotal survival advantage(s) to the overall cancer cell population; 2) construction of a potent and durable target-specific therapeutic agent; and 3) deployment… More